SRTANasdaqServices-Health ServicesFiscal year ends December 31
Strata Critical Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$4.54+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $391.41M
- P/E (TTM)
- 8.9
- Dividend yield
- –
Share price
−$0.45 (−9.02%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Strata Critical Medical, Inc. grew revenue 66.8% to $255.98M over the twelve months to Jun 30, 2026. Free cash flow was -$48.45M.
Revenue
$255.98M
+66.8% vs. a year earlier
Operating income
-$20.41M
TTM Q2 2026
Free cash flow
-$48.45M
TTM Q2 2026
EPS, diluted
$0.51
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $391.41M
- P/E ratio
- 8.9
- Price to sales
- 1.53
- Price to book
- 1.40
- Dividend yield
- –
- Free cash flow yield
- -12.38%
Fundamentals
- Revenue
- $255.98M
- Net income
- $40.22M
- EPS, diluted
- $0.51
- Free cash flow
- -$48.45M
- Book value per share
- $3.24
- Diluted shares
- 86M
Seven years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$255.98M+66.8% YoY
Gross profit
$52.62M+84.1% YoY
Operating income
-$20.41M
Net income
$40.22M
EPS, diluted
$0.51
Free cash flow
-$48.45M
Reported periodTrailing twelve months